https://parvustx.com/publications/autoimmunity-antigen-specific-immunotherapy/ 2021-09-10T16:05:20+00:00 https://parvustx.com/publications/umeshappa-et-al-2020-ubiquitous-antigen-specific-t-regulatory-type-1-cells-variably-suppress-hepatic-and-extrahepatic-autoimmunity-j-clin-invest-1301823/ 2021-09-10T16:08:23+00:00 https://parvustx.com/publications/jamaleddine-et-al-2020-quantifying-immunoregulation-by-autoantigen-specific-t-regulatory-type-1-cells-in-mice-with-simultaneous-hepatic-and-extra-hepatic-autoimmune-disorders-immunology-161209/ 2021-09-10T16:09:33+00:00 https://parvustx.com/publications/umeshappa-et-al-2019-suppression-of-a-broad-spectrum-of-liver-autoimmune-pathologies-by-single-peptide-mhc-based-nanomedicines-nat-commun-102150/ 2021-09-10T16:16:45+00:00 https://parvustx.com/publications/hebbandi-nanjundappa-et-al-2017-a-gut-microbial-mimic-that-hijacks-diabetogenic-autoreactivity-to-suppress-colitis-cell-171655/ 2021-09-10T16:18:58+00:00 https://parvustx.com/publications/singha-et-al-2017-peptide-mhc-based-nanomedicines-for-autoimmunity-function-as-t-cell-receptor-microclustering-devices-nat-nanotechnol-12701/ 2021-09-10T16:21:13+00:00 https://parvustx.com/publications/clemente-casares-et-al-2016-expanding-antigen-specific-regulatory-networks-to-treat-autoimmunity-nature-530434/ 2021-09-10T16:22:49+00:00 https://parvustx.com/publications/khadra-et-al-2010-on-how-monospecific-memory-like-autoregulatory-cd8-t-cells-can-blunt-diabetogenic-autoimmunity-a-computational-approach-j-immunol-1855962/ 2021-09-10T16:24:59+00:00 https://parvustx.com/publications/october-29-2019-serra-et-al-2019-increased-yields-and-biological-potency-of-knob-into-hole-based-soluble-mhc-class-ii-molecules-nat-commun-104917/ 2021-09-24T11:31:29+00:00 https://parvustx.com/publications/jagadeesh-2016-repressing-immunity-in-autoimmune-disease-nejm-3742090/ 2021-09-27T18:46:27+00:00 https://parvustx.com/publications/clemente-casares-et-al-2016-expanding-antigen-specific-regulatory-networks-to-treat-autoimmunity-nature-530434-2/ 2021-09-27T19:53:41+00:00 https://parvustx.com/publications/wraith-2016-autoimmunity-antigen-specific-immunotherapy-nature-530422/ 2021-09-27T19:56:48+00:00 https://parvustx.com/publications/serra-et-al-2021-peptide-mhc-based-nanomedicines-for-the-treatment-of-autoimmunity-engineering-mechanisms-and-diseases-frontiers-in-immunology-11621774/ 2021-10-07T17:07:28+00:00 https://parvustx.com/publications/yang-et-al-2021-extremely-short-bioavailability-and-fast-pharmacodynamic-effects-of-pmhc-based-nanomedicines-j-control-release-33557/ 2021-10-07T17:08:44+00:00 https://parvustx.com/publications/sole-et-al-2021-therapeutic-re-programming-of-autoantigen-experienced-t-cells-into-t-regulatory-type-1-cells-for-the-treatment-of-autoimmunity-frontiers-in-immunology-12-684240/ 2021-10-07T17:10:01+00:00 https://parvustx.com/publications/carballido-et-al-2019-taming-autoimmunity-translating-antigen-specific-approaches-to-induce-immune-tolerance-jem-216247/ 2021-10-07T17:15:13+00:00 https://parvustx.com/publications/serra-et-al-2019-antigen-specific-therapy-approaches-for-autoimmunity-nat-bio-37238/ 2021-10-07T17:17:34+00:00 https://parvustx.com/publications/serra-et-al-2018-nanoparticle-based-approaches-to-immune-tolerance-for-the-treatment-of-autoimmune-diseases-eji-48751/ 2021-10-07T17:20:32+00:00 https://parvustx.com/publications/tsai-et-al-2010-reversal-of-autoimmunity-by-boosting-memory-like-autoregulatory-t-cells-immunity-32568-2/ 2021-10-07T17:23:49+00:00 https://parvustx.com/publications/umeshappa-et-al-2021-liver-specific-t-regulatory-type-1-cells-program-local-neutrophils-to-suppress-hepatic-autoimmunity-via-cramp-cell-rep-34108919/ 2021-10-07T22:36:19+00:00 https://parvustx.com/publications/umeshappa-et-al-2019-suppression-of-a-broad-spectrum-of-liver-autoimmune-pathologies-by-single-peptide-mhc-based-nanomedicines-nat-commun-102150-2/ 2022-12-19T04:45:20+00:00 https://parvustx.com/publications/sole-et-al-2023-a-t-follicular-helper-cell-origin-for-t-regulatory-type-1-cells-cellular-and-molecular-immunology/ 2023-04-07T06:55:22+00:00 https://parvustx.com/publications/umeshappa-et-al-2022-re-programming-liver-resident-invariant-natural-killer-t-cells-to-suppress-hepatic-and-diabetogenic-autoimmunity-nature-communications-13-3279/ 2023-04-07T06:55:53+00:00 https://parvustx.com/publications/yang-et-al-2022-antigen-specific-nanomedicines-for-the-treatment-of-autoimmune-disease-target-cell-types-mechanisms-and-outcomes-current-opinion-in-biotechnology-74285-292/ 2023-04-07T06:56:50+00:00 https://parvustx.com/publications/sole-et-al-2023-transcriptional-re-programming-of-insulin-b-chain-epitope-specific-t-follicular-helper-cells-into-anti-diabetogenic-t-regulatory-type-1-cells-front-immunol-in-press/ 2023-05-08T18:39:44+00:00 https://parvustx.com/publications/can-autoimmune-diseases-be-cured-scientists-see-hope-at-last/ 2024-04-26T19:13:38+00:00 https://parvustx.com/publications/yang-et-al-2021-evolution-of-nanomedicines-for-the-treatment-of-autoimmune-disease-from-vehicles-for-drug-delivery-to-inducers-of-bystander-immunoregulation-advanced-drug-delivery-reviews-1761/ 2024-04-26T19:15:09+00:00